November 17, 2026

Report · Palestine

Captive Economy

The pharmaceutical industry and the Israeli occupation

by Who Profits Research Center · 2012

About the report

This Who Profits report examines how Israeli and multinational drug companies profit from the occupation’s control over the Palestinian pharmaceutical market.

It shows how the Paris Protocol and Israeli regulations turned the occupied territory into a captive market: Israeli companies such as Teva, Perrigo, Taro and Dexcel sell freely, without the checkpoint delays and extra costs that Palestinian producers face, while Palestinian manufacturers face obstacles selling in East Jerusalem and Israel and struggle to export. Meanwhile public pharmacies, in Gaza especially, suffer chronic shortages of essential drugs.

Read the report? Take the next step.

Join a Palestine solidarity group near you, travel with a delegation to Palestine, or become part of Solidarity Rising.

Related resources

Solidarity Rising

In solidarity with all oppressed peoples for the common pursuit of justice and freedom for all.

Registered in Sweden
Registration No. 802527-7537

Email: team@solidarityrising.com

Get posted